Of note, in hepatocytes, GDF15 expression is considered to be promoted by interleukin (IL)-1β signaling and ER stress which are involved in MASLD development and progression [58, 59]. Here, GDF15 is linked to metabolic dysfunction-associated steatotic liver disease.